Trial intelligence / Profile preview

Hydrocortisone in Very Preterm Infants

NCT00167544Phase 2Completed

Sponsor
Nationwide Children's Hospital
Start
Nov 2005
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of hydrocortisone in bronchopulmonary dysplasia (BPD), encephalomalacia, sponsored by Nationwide Children's Hospital. Started Nov 2005; status: completed.

02

Drugs

hydrocortisone
03

Conditions

bronchopulmonary dysplasia (BPD)encephalomalacia

Beyond the preview

Go deeper on NCT00167544.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00167544.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call